Scholar Rock Bringing First SMA Add-On Treatment To US Patients, At $310,000 Net Cost Scrip Pharma Intelligence 1d
Scholar Rock Marks 'Defining Moment' with First Muscle-Targeted Treatment for Spinal Muscular Atrophy Benzinga 1d Article paywall
Record-setting cyclospora outbreak is over, U.S. health officials say CBS News 4d Cyclospora All sources
Delhi HC rejects Vimal Elaichi maker’s plea over notices to Shah Rukh Khan, Ajay Devgn, Tiger Shroff The Times of India 1d Vimal Elaichi Ajay Devgn Delhi All sources
FDA approves apitegromab, first muscle-targeting therapy for children and adults with SMA Rare Disease Advisor 1d Scholar Rock Pharma All sources
Protein degrading breast cancer drugs navigate bumpy road to market Chemistry World Magazine 8h Breast Cancer Cancer Treatment Cancer All sources
